Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA

Area of Science:

• Biomarker Discovery
• Molecular Diagnostics
• Clinical Chemistry

Background:

• Circulating cell-free DNA (cfDNA) is a promising biomarker with established uses in oncology and prenatal testing.
• Research into cfDNA applications is expanding to areas including cardiovascular diseases, diabetes, and transplantation.
• Clinical implementation is hindered by a lack of standardization in cfDNA analysis.

Purpose of the Study:

• To systematically review preanalytical variables and patient factors influencing cfDNA analysis.
• To propose guidelines for the analysis of nuclear cfDNA based on scientific data.
• To address the need for standardization in cfDNA testing.

Main Methods:

• Conducted a systematic literature search on MEDLINE for preanalytical factors in cfDNA analysis.
• Focused on identifying relevant preanalytical variables and patient factors.
• Synthesized findings to form the basis for proposed guidelines.

Main Results:

• Identified key preanalytical variables and patient factors critical for cfDNA analysis.
• Highlighted the scarcity of pooled scientific data and established standard operating procedures.
• Established a foundation for developing standardized cfDNA analysis protocols.

Conclusions:

• Standardization of preanalytical factors is essential for the broader clinical adoption of cfDNA biomarkers.
• The proposed guidelines aim to improve the reliability and reproducibility of cfDNA testing.
• Further research and consensus are needed to establish universal cfDNA analysis standards.